A pharmaceutical preparation comprising—10 to 200 μg/ml of fragments of an antigenic structure which induces allergic reaction—2 to 6% (w/v) mannitol—0.5 to 2% (w/v) trehalose—water, wherein said preparation essentially does not comprise heat shock proteins.